Salih, Teresita T.
HRN: 21-53-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/06/2022
08/12/2022
IV
500mg
Q24
CAP HR
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines